English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Feb 8, 2026

Bio-detection dogs identify scent signature of aggressive canine cancer
+ Pharmaceuticals
Patient Daily | Feb 8, 2026

Study links severe vitamin D deficiency with higher hospitalizations for respiratory infections
+ Pharmaceuticals
Patient Daily | Feb 6, 2026

AbbVie emphasizes potential of new psychedelic therapy as market interest grows
+ Pharmaceuticals
Patient Daily | Feb 6, 2026

Researchers link genetic variants affecting lipid metabolism with Parkinson's risk
+ Pharmaceuticals
Patient Daily | Feb 6, 2026

La Trobe researchers develop highly sensitive test strip for disease detection
+ Pharmaceuticals
Patient Daily | Feb 6, 2026

New therapy may offer monthly alternative to daily pills after kidney transplantation
+ Pharmaceuticals
Patient Daily | Feb 6, 2026

Duplicate medical records linked to increased risk of death in US hospitals
+ Pharmaceuticals
Patient Daily | Feb 6, 2026

Lack of pediatric data limits access to key antibiotics for severe childhood infections

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones